Age-related degenerative and malignant diseases represent major challenges for health care systems. Elucidation of the molecular mechanisms underlying carcinogenesis and age-associated pathologies is thus of growing biomedical relevance. We identified biallelic germline mutations in SPRTN (also called C1orf124 or DVC1) 1-7 in three patients from two unrelated families. All three patients are affected by a new segmental progeroid syndrome characterized by genomic instability and susceptibility toward early onset hepatocellular carcinoma. SPRTN was recently proposed to have a function in translesional DNA synthesis and the prevention of mutagenesis 1-7 . Our in vivo and in vitro characterization of identified mutations has uncovered an essential role for SPRTN in the prevention of DNA replication stress during general DNA replication and in replication-related G2/M-checkpoint regulation. In addition to demonstrating the pathogenicity of identified SPRTN mutations, our findings provide a molecular explanation of how SPRTN dysfunction causes accelerated aging and susceptibility toward carcinoma.
l e t t e r s low body weight, micrognathia, triangular face, muscular atrophy, lipodystrophy, bilateral simian creases, delayed bone age and mild joint restrictions in the fingers and elbows. Although hepatitis A, B and C serologies and α-fetoprotein levels were normal in these two boys, both developed early onset HCC at age 16 and 14, respectively (Fig. 1c) . B-II:1 died at age 18 years from complications of acute fulminant hepatic failure. The clinical characteristics of all three affected individuals are summarized and compared to those of known segmental progeroid syndromes in Table 1 .
To identify the genetic cause of this putatively autosomalrecessive segmental progeroid disorder, we performed genome-wide linkage analysis ( Supplementary Fig. 1 ) followed by exome sequencing of unrelated individuals A-IV:1 and B-II:4. Bioinformatic filtering identified SPRTN as the only gene with rare, biallelic mutations in the exomes of both individuals ( Supplementary Tables 1 and 2 ). In A-IV:1, a 1-bp deletion at cDNA position 721 bp (c.721delA) was the only nonannotated sequence change with a severe impact on protein structure within the homozygous regions and is predicted to introduce a premature stop codon at amino acid 249 (p.Lys241AsnfsX8). B-II:4 was compound heterozygous for a c.350A>G missense alteration, resulting in the amino acid substitution p.Tyr117Cys, and a 4-bp deletion at cDNA position 717 bp (c.717_718+2delAGGT). At the cDNA level, this deletion predominantly caused intron inclusion, inducing a premature stop codon at amino acid 246 (p.Lys239LysfsX7). A very small fraction of cDNA demonstrated skipping of exon 4, resulting in a premature stop at position 161 bp (p.Val151IlefsX10) ( Supplementary Fig. 2a-c ). This finding was further supported by protein analysis, which identified a reduced amount of full-length protein and a new truncated protein (Fig. 1d) . Sanger sequencing confirmed the mutations in all three patients (Supplementary Fig. 2d ) and cosegregation with disease state in their families (Supplementary Table 3 ). None of these variants was present in dbSNP137 or the 1000 Genomes data. The substitution p.Tyr117Cys is located in a putative zinc metalloprotease SprT domain five amino acids upstream of Glu112, which was recently shown to be necessary for the regulation of error-prone translesional DNA synthesis (TLS) 5 . The identified truncating mutations (∆C-ter SPRTN) lead to the loss of functionally important C terminal-located domains, including the ubiquitinsegregase p97 (VCP) 16 -interacting motif (SHP), the proliferating cell nuclear antigen interacting box (PIP) and the ubiquitin binding domain (UBZ4; Fig. 1e ). The C-terminal part of SPRTN has an essential function at ultraviolet (UV)-induced stalled replication forks by the removal of DNA polymerase η in a p97-dependent manner after the completion of TLS 2, 3 . Taken together, these genetic findings have already provided strong evidence for the pathogenicity of the identified mutations. The analysis of 48 additional patients with suspected Werner syndrome but without mutations in WRN or LMNA 14 revealed no other SPRTN mutation, providing further evidence of extended locus heterogeneity for segmental progeroid syndromes.
We next performed morphological and immunohistochemical analyses of patients' liver tumor biopsies. Staining with a C-terminal SPRTN antibody (Fig. 2a) showed the absence of the C-terminal part of SPRTN in A-IV:1, thus confirming the truncation of the mutated protein in A-IV:1 in vivo. We observed focal accumulations of anti-SPRTN immunoreactive material in B-II:1 and B-II:4, as well as in idiopathic HCC. In vitro analysis of focal nuclear accumulation of ectopically expressed wild-type (WT) SPRTN and mutant SPRTN from patients additionally supported the in vivo finding and disclosed that WT and p.Tyr117Cys SPRTN are able to form nuclear foci, but ∆C-ter SPRTN is not (Fig. 2b) . Analyses of cancer biomarkers revealed strong focal accumulations of both γ-H2AX (H2AFX) and 53BP1 (TP53BP1) (Fig. 2a) . In addition, and opposite to what we observed in patient primary cell lines (Fig. 3a-c) , Ki-67 (MKI67) staining in the biopsies of A-IV:1, B-II:1 and B-II:4 indicated a high proliferative index compared to healthy liver or idiopathic HCC (Fig. 2a) . These data suggest a relatively aggressive neoplasm 17, 18 .
We next tested whether the cellular phenotypes described previously in A-IV:1, namely chromosomal instability with concomitant sensitivity toward genotoxic agents and severe proliferation defects 15 , were also present in primary cell lines from B-II:1 and B-II:4. Indeed, we found increased chromosomal instability in peripheral blood (Supplementary Fig. 3 ) and lymphoblastoid cell lines (LCLs) from the patients, which was enhanced after treatment with mitomycin C (MMC) and 4-nitroquinoline 1-oxide (4-NQO) (Fig. 3d) . In patient npg l e t t e r s fibroblasts, we observed multiple and variable aberrations that were clonal in nature ( Supplementary Fig. 4 ), which is compatible with variegated translocation mosaicism, a phenomenon previously described in Werner syndrome cells 19 . Measurement of a proliferation index revealed a severe growth defect in cultured B-II:1 fibroblasts ( Fig. 3a-c To assess the consequences of patient mutations in an in vivo complementation assay, we performed morpholino-mediated downregulation of the SPRTN ortholog in zebrafish (LOC101886162, called here sprtn). sprtn silencing, verified by a GFP reporter assay ( Supplementary Fig. 7a ), led to a substantial increase of γ-H2AX foci ( Supplementary Fig. 7b,c) , indicating an evolutionarily conserved functional role of SPRTN in the DNA damage response. When injecting higher doses of morpholino, embryos displayed phenotypically normal development until the shield stage at 6 h post fertilization (hpf ), a stage when maternal gene products are degraded 20 . At 10 hpf, however, embryos exhibited either early mortality or were delayed in development up to 4 h. This growth retardation phenotype is compatible with the proliferation defects observed in patients' fibroblasts and the relative growth deficits observed in patients. This phenotype was partially rescued by co-injection of WT human SPRTN mRNA but not by equimolar amounts of mRNA from SPRTN harboring the identified mutations (Fig. 3e,f) , thus further confirming their pathogenicity.
The lack of sun sensitivity and the presence of severe chromosomal breakage, proliferation defects and early onset HCC in patients indicated a more complex role of SPRTN in the maintenance of genome stability than solely TLS, as was proposed recently [1] [2] [3] [4] [5] [6] [7] . Defects in DNA replication have been proposed to be a major cause of the variegated translocation mosaicism and genomic instability that consequently lead to aging and cancer [21] [22] [23] . To test for a role of SPRTN in DNA replication, we analyzed the progression of replication forks directly by npg l e t t e r s DNA fiber assay (Fig. 4a) , the clearest method to unambiguously characterize the DNA replication machinery 24 . The speed of DNA replication was significantly but only mildly affected in patients' LCLs under unchallenged conditions (Fig. 4b) , but increased levels of stalled forks (Fig. 4c) and newly fired origins (Fig. 4d) indicated DNA replication stress as the cause of DNA damage in these patients 25 . When we treated LCLs with a low dose of aphidicolin (APH), mimicking the physiological barriers the DNA replication machinery approaches during DNA synthesis 26 , patients' cells showed a typical signature of DNA replication stress, namely shorter replication forks than in control cells (Fig. 4e,f) . This observation is comparable to cellular findings in Werner and Bloom syndromes 27, 28 . Moreover, B-II:1 fibroblasts showed markedly increased numbers of double-strand breaks (DSBs) in S-phase cells (Supplementary Fig. 8 ). To further confirm that mutations in SPRTN are the cause of the DNA replication defect, we transfected patients' cells with WT SPRTN, which almost completely corrected the replication defect ( Fig. 4g and Supplementary  Fig. 9a ) and restored cellular proliferation (Supplementary Fig. 9b,c) . siRNA-mediated SPRTN depletion severely affected the progression of DNA replication and induced an increased number of stalled forks, newly fired origins and formation of DSBs in the S phase of the cell cycle ( Supplementary Fig. 10 ), providing further evidence of the role of SPRTN in general DNA replication. Notably, depletion of DNA polymerase η in patients' cells or in SPRTN-depleted U2OS cells did not complement the DNA replication phenotype ( Supplementary  Fig. 11 ), suggesting that DNA polymerase η is not the main substrate, as reported previously 2, 3 .
To evaluate how replication-related DNA damage is transferred to mitosis and may thus contribute to chromosomal instability, we measured the ability of patients' cells to activate the G2/M checkpoint, the main guardian of genome stability after DNA replication stress 29 . We exposed patients' LCLs to different genotoxic agents and measured the arrival of cells to mitosis by flow cytometry (Fig. 4h-j and Supplementary Figs. 12 and 13) . We observed a severe G2/M-checkpoint defect in cells from B-II:1 and B-II:4 after treatment with genotoxic agents that interfere with DNA replication, such as camptothecin (CPT) (Fig. 4h-j) , a topoisomerase I inhibitor that causes replication-related DSBs, or UV radiation (Supplementary Fig. 13) . Notably, the G2/M checkpoint was completely functional when we created random and non-replication related DSBs using ionizing radiation (Supplementary Fig. 13 ). The hypersensitivity of patient cells to replication-related genotoxic agents but not to ionizing radiation (Supplementary Fig. 14) correlates with G2/M leakage.
To further assess the role of patients' mutations in DNA replication and G2/M-checkpoint regulation, we tested their function in U2OS cells that we depleted of endogenous SPRTN using siRNA ( Fig. 5  and Supplementary Fig. 15 ). Ectopic expression of WT SPRTN restored DNA replication and G2/M-checkpoint defects. The expression of ∆C-ter SPRTN was also able to restore the progression of the DNA replication fork but to a much lesser extent then WT SPRTN, suggesting that this mutant is defective in proper DNA synthesis (Fig. 5b) . The difference in efficacy was even more pronounced when we exposed cells to mild replication stress (APH treatment; Fig. 5c) , further supporting the function of the C-terminal part of SPRTN in TLS. Notably, the cells ectopically expressing p.Tyr117Cys SPRTN were completely unable to restore DNA replication fork progression, suggesting the essential role of the SprT domain in general DNA replication. We obtained similar results in HEK293 cells (data not shown). In contrast to DNA replication, cells expressing either of the patient mutations or coexpressing both mutations were equally defective in activation of the G2/M checkpoint after exposure to UV radiation or CPT treatment (Fig. 5d and data not shown) , indicating the communal function of the SprT domain and the C-terminal part of SPRTN in the regulation of the G2/M-checkpoint response. Taken together, these data demonstrate that SPRTN dysfunction leads to sustained DNA replication stress and consequent replication-related DNA damage, especially DSBs, which are transferred to the next cell generation because of a leakage of the G2/M checkpoint and, consequently, lead to cancer or aging. The bar graph summarizes analyses in more than 100 embryos in three independent experiments showing the distribution of phenotypes observed after injections with 17.6 ng of MO and co-injections of 100 pg of SPRTN mRNA. P values in e were calculated using the χ 2 test. *P < 0.01, **P < 0.001, ***P < 0.0001 (a,c-e). (f) Western blot analysis of the experiment shown in e. Sprtn, endogenous zebrafish protein; SPRTN, ectopically expressed human protein.
l e t t e r s
Studying the genetic and cellular basis of monogenic segmental progeroid and tumor susceptibility syndromes has been a meaningful approach in unraveling the molecular mechanisms and pathways involved in the regulation of cancer development and common diseases of the elderly 8 . HCC, although rarely occurring before the age of 40 years 30 , is the fifth most common malignancy and the third leading cause of cancer-related death worldwide 31 were analyzed by DNA fiber assay. 1 µm of DNA tract length corresponds to 2.6 kb of newly synthesized DNA 32 . n = 3; more than 100 DNA fibers analyzed per experiment and per condition. (d) U2OS cells, as in a, were analyzed for the efficacy of the G2/M checkpoint after treatment with UV radiation, as described in Figure 4 . The graph summarizes three independent experiments. The data in b and c are presented as the median (bar) with the 25th-75th percentile range (box) and the 10th-90th percentile range (whiskers). Data in d are shown as a bar graph with the mean ± s.e.m. Data in b-d were analyzed with unpaired two-tailed t-test. *P < 0.05, **P < 0.001, ***P < 0.0001. NS, no significant difference between the groups. npg infection and alcohol abuse, the molecular pathogenesis of HCC remains largely elusive. All three patients presented here-in addition to showing signs of accelerated aging in selected tissues-developed early onset HCC, identifying SPRTN as a monogenic and apparently highly penetrant susceptibility gene for HCC. Consequently, our findings suggest SPRTN as the subject of future studies of hepatocarcinogenesis and therapy.
